These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22004953)

  • 21. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue.
    Yang Y; Faustino PJ; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Yu LX; Khan MA; Lyon RC
    Int J Pharm; 2008 Apr; 353(1-2):187-94. PubMed ID: 18226478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Prussian blue and sodium-ethylenediaminetetraacetic acid on the faecal and urinary elimination of thallium by the dog.
    van der Stock J; de Schepper J
    Res Vet Sci; 1978 Nov; 25(3):337-42. PubMed ID: 107548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
    J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
    Lucić Vrdoljak A; Radić B; Garaj-Vrhovac V; Kopjar N; Zlender V
    J Appl Toxicol; 2006; 26(1):56-63. PubMed ID: 16167315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding.
    Mohammad A; Faustino PJ; Khan MA; Yang Y
    Int J Pharm; 2014 Dec; 477(1-2):122-7. PubMed ID: 25311178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
    Seaton CL; Lasman J; Smith DR
    Toxicol Appl Pharmacol; 1999 Sep; 159(3):153-60. PubMed ID: 10486301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of thallium poisoning in patients with delayed hospital admission.
    Sun TW; Xu QY; Zhang XJ; Wu Q; Liu ZS; Kan QC; Sun CY; Wang L
    Clin Toxicol (Phila); 2012 Jan; 50(1):65-9. PubMed ID: 22175787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
    Kalia K; Narula GD; Kannan GM; Flora SJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan; 144(4):372-9. PubMed ID: 17188940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Check of Prussian blue for antidotal efficacy in thallium intoxication.
    Rauws AG; van Heyst AN
    Arch Toxicol; 1979 Dec; 43(2):153-4. PubMed ID: 533372
    [No Abstract]   [Full Text] [Related]  

  • 32. [Iron (III) hexacyanoferrate (II) hydrate Prussian blue insoluble)].
    Kuroki Y
    Chudoku Kenkyu; 2013 Sep; 26(3):254-8. PubMed ID: 24224393
    [No Abstract]   [Full Text] [Related]  

  • 33. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR; Woolard D; Luck ML; Laughlin NK
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
    Gong Z; Evans HL
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of thallium poisoning.
    Pau PW
    Hong Kong Med J; 2000 Sep; 6(3):316-8. PubMed ID: 11025853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat.
    Mahaffey KR; Capar SG; Gladen BC; Fowler BA
    J Lab Clin Med; 1981 Oct; 98(4):463-81. PubMed ID: 7288264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eleven cases of thallium intoxication treated with Prussian blue.
    Stevens W; van Peteghem C; Heyndrickx A; Barbier F
    Int J Clin Pharmacol; 1974 Jul; 10(1):1-22. PubMed ID: 4851835
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective effect of Smilax glabra extract against lead-induced oxidative stress in rats.
    Xia D; Yu X; Liao S; Shao Q; Mou H; Ma W
    J Ethnopharmacol; 2010 Jul; 130(2):414-20. PubMed ID: 20580805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxicity of thallium: biochemical and morphological study of organic lesions.
    Barroso-Moguel R; Ríos-Castañeda C; Villeda-Hernández J; Méndez-Armenta M; Galván-Arzate S
    Arch Invest Med (Mex); 1990; 21(2):115-22. PubMed ID: 2103698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.